Leishmania mexicana infection of the eyelid in a traveler to Belize

Brazilian Journal of Infectious Diseases

Volumn 10, Issue 4, 2006, Pages 304-306

  Vinetz, Joseph M ^a   Soong, Lynn ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Belize; Leishmania mexicana; Traveler

Indexed keywords

ITRACONAZOLE; STIBOGLUCONATE SODIUM;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BELIZE; CASE REPORT; EYELID DISEASE; FOLLOW UP; FOOT PAD; HUMAN; INFECTION CONTROL; LEISHMANIA MEXICANA; MALAISE; MALE; MOUSE; MYALGIA; NONHUMAN; PARASITE ISOLATION; PATIENT EDUCATION; RELAPSE; REPEATED DRUG DOSE; SIDE EFFECT; SKIN BIOPSY; SKIN DEFECT; SKIN LEISHMANIASIS; T WAVE; TRAVEL; TREATMENT OUTCOME; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; UNITED STATES; WOUND HEALING;

EID: 33947359051     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1413-86702006000400016     Document Type: Article

References (26)

1. Desjeux P. Leishmaniasis. Nat Rev Microbiol 2004;2:692.
2. Herwaldt B. Leismaniasis. Lancet 1999;354:1191-11.
3. Marsden P.D. Mucosal Leishmaniasis ("espundia" Escomel, 1911), Trans R Soc Trop Med Hyg 1986;80:859-76.
4. Lawn S.D., Whetham J., Chiodini P.L., et al. New World mucosal and cutaneous leishmaniasis: an emerging health problem among British travellers. QJM 2004;97:781-8.
5. Zeegelaar J.E., Steketee W.H., van Thiel P.P.A.M., et al. Changing pattern of imported cutaneous leishmaniasis in the Netherlands. Clin Exp Dermatol 2005;30:1-5.
6. Hepburn N.C., Tidman M.J., Hunter J.A. Cutaneous leishmaniasis in British troops from Belize. Br. J Dermatol 1993;128;63-8.
7. Palmer R.A., Tran D., Hepburn N.C., Ashton R.E. The management of cutaneous leishmaniasis from Belize. Clin Exp Dermatol 2001;26:16-20.
8. Enserink M. Infectious diseases. Has leishmaniasis become endemic in the U.S.? Science 2000;290:1881-3.
9. Update: Cutaneous leishmaniasis in U.S. military personnel-Southwest/ Central Asia, 2002-2004. MMWR Morb Mortal Wkly Rep 2004;53:264-5.
10. Cutaneous Leishmaniasis in U.S. Military personnel - Southwest/Central Asia, 2002-2003. MMWR Morb Mortal Wkly Rep 2003;52:1009-12.
11. Magil A.J., Grol M., Gasser R.A., Jr., Sun W., Oster C.N. Visceral infection caused by Leishmania tropica in veterans of Operation Desert Storm. N Engl J Med 1993;328:1383-7.
12. Martin S., Gambel J., Jackson J., et al. Leishmaniasis in the United States military. Mil. Med 1998;163:801-7.
13. Jaramillo R., Bryan J.P., Schur J., Pan A.A. Prevalence of antibody to Trypanosoma cruzi in three populations in Belize. Am J Trop Med Hyg 1997;57:298-301.
14. Chu F.C., Rodrigues M.M., Cogan D.G., Neva F.A. Leishmaniasis affecting the eyelids. Arch Ophthalmol 1983;101:84-91.
15. Rentsch F.J. Cutaneous leishmaniasis (Oriental sore) of the lids. Klin Monatsbl Augenheilkd 1980;177:75-9.
16. Ferry A.P. Cutaneous leishamaniasis (oriental sore) of the eyelid. Am J Ophthalmol 1977;84:349-54.
17. Morgan G. Case of cutaneous leishmaniasis of the lid. Br J Ophthalmol 1965;49:542-6.
18. Brown M., noursadeghi M., Boyle J., Davidson R.N. Successful liposomal amphotericin B treatment of Leishmania braziliensis cutaneous leishmaniasis. Br J Dermatol 2005;153:203-5.
19. Calvopina M., Guevara A.G., Armijos R.X., et al. Itraconazole in the treatment of New World mucocutaneous leishmaniasis. Int J Dermatol 2004;43:659-63.
20. Borelli D. A clinical trial of itraconazole in the treatment of deep mycoses and leishmaniasis. Rev Infect Dis 1987;Suppl 1 S57-S63.
21. Dogra J., Saxena V.N. Itraconazole and leishmaniasis: a randomized double-blind trial in cutaneous disease. Int J Parasitol 1996;26:1413-5.
22. Gardlo K., Horska Z., Enk C.D., et al. Treatment of cutaneous leishamaniasis by photodynamic therapy. J Am Acad Dermatol 2003;48:893-6.
23. Gonçalves G.S., Fernandes A.P., Souza R.C., et al. Activity of a paromomycin hydrophilic formulation for topical treatment of infectious Leishmania (Leishmania) amazonnensis and Leishmania (Viannia) braziliensis. Acta Trop 2005;93:161-7.
24. Miranda-Verastegui C., Llanos-Cuentas A., Arevalo I., et al. Randomized, double-blind clinical trial of topical imiquimod 5% with parenteral meglumine antimoniate in the treatment of cutaneous leishmaniasis in Peru. Clin Infect Dis 2005;40:1395-403.
25. Seeberger J., Daoud S., Pammer J. Transient effect of topical treatment of cutaneous leishmaniasis with imiquimod. Int J Dermatol 2003;42:576-9.
26. Arevalo I., Ward B., Miller R., et al. Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod and immunomodulator. Clin Infect Dis 2001;33:1847-51.